Literature DB >> 31298578

PLK1 inhibition in cancer therapy: potentials and challenges.

Inas Elsayed1,2,3,4, Xiaosheng Wang1,2,3.   

Abstract

Entities:  

Keywords:  PLK1; PLK1 inhibitors; cancer therapy

Mesh：

Substances：

Year:  2019        PMID： 31298578     DOI： 10.4155/fmc-2019-0084

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  5 in total

1.  ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.

Authors:  Guoxin Hou; Zhimin Lu; Yanyu Bi; Jingjing Deng; Xinmei Yang
Journal:  Med Oncol       Date:  2022-02-12       Impact factor: 3.064

2.  PLK1 inhibition selectively induces apoptosis in ARID1A deficient cells through uncoupling of oxygen consumption from ATP production.

Authors:  Upadhyayula S Srinivas; Norbert S C Tay; Patrick Jaynes; Akshaya Anbuselvan; Gokula K Ramachandran; Joanna D Wardyn; Michal M Hoppe; Phuong Mai Hoang; Yanfen Peng; Sherlly Lim; May Yin Lee; Praveen C Peethala; Omer An; Akshay Shendre; Bryce W Q Tan; Sherlyn Jemimah; Manikandan Lakshmanan; Longyu Hu; Rekha Jakhar; Karishma Sachaphibulkij; Lina H K Lim; Shazib Pervaiz; Karen Crasta; Henry Yang; Patrick Tan; Chao Liang; Lena Ho; Vartika Khanchandani; Dennis Kappei; Wei Peng Yong; David S P Tan; Matteo Bordi; Silvia Campello; Wai Leong Tam; Christian Frezza; Anand D Jeyasekharan
Journal:  Oncogene       Date:  2022-03-02       Impact factor: 9.867

3.  Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas.

Authors:  Roberta Affatato; Michela Chiappa; Federica Guffanti; Francesca Ricci; Laura Formenti; Robert Fruscio; Marta Jaconi; Maya Ridinger; Mark Erlander; Giovanna Damia
Journal:  Ther Adv Med Oncol       Date:  2022-05-31       Impact factor: 5.485

4.  Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile.

Authors:  Sisi Deng; Xiaoli Lu; Zhi Zhang; Rui Meng; Mi Li; Shilin Xia
Journal:  J Cell Mol Med       Date:  2021-06-02       Impact factor: 5.310

5.  Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.

Authors:  Shengqiang Zhang; Hongyan Zhang; Huawei Li; Jida Guo; Jun Wang; Linyou Zhang
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.